The Pharmacologist 2 0 0 6 June
Total Page:16
File Type:pdf, Size:1020Kb
Vol. 48 Number 2 The Pharmacologist 2 0 0 6 June Experimental Biology 2006 San Francisco Inside this Issue EB ’06 in Review Message from President Barrett Axelrod Award Announcement ASPET Committees for 2006- 2007 ASPET Centennial Feature - New! Honoring 50 years of ASPET Membership ASPET Members Survey A Publication of the American Society for 45 Pharmacology and Experimental Therapeutics - ASPET Volume 48 Number 2, 2006 The Pharmacologist is published and distributed by the American Society for Pharmacology and Experimental Therapeutics. The Editor PHARMACOLOGIST Suzie Thompson EDITORIAL ADVISORY BOARD Bryan F. Cox, Ph.D. News Ronald N. Hines, Ph.D. Donald E. McMillan, Ph.D. Experimental Biology ‘06 . page 45 COUNCIL President More Pictures from EB ‘06 . page 47 James E. Barrett, Ph.D. President-Elect Farewell Message from the President . page 48 Elaine Sanders-Bush, Ph.D. Julius Axelrod Award . page 50 Past President Stephen G. Holtzman, Ph.D ASPET Committees for 2006-2007. page 51 Secretary/Treasurer Patricia K. Sonsalla, Ph.D. Features Secretary/Treasurer-Elect Lynn Wecker, Ph.D. Past Secretary/Treasurer Journals . page 55 James R. Halpert, Ph.D Public Affairs & Government Relations . page 58 Councilors Division News Bryan F. Cox, Ph.D. Ronald N. Hines, Ph.D. Drug Metabolism Division News. page 60 Donald E. McMillan, Ph.D. Division Mixers Pictures from EB ‘06 . page 62 Chair, Board of Publications Trustees Brian M. Cox, Ph.D. Centennial Update . page 63 Chair, Program Committee Members in the News. page 64 Jack Bergman, Ph.D. FASEB Board Representative Staff News . page 64 David B. Bylund New ASPET Members. page 65 Executive Officer Christine K. Carrico, Ph.D. Fifty Year ASPET Members. page 66 Death Notices. page 67 The Pharmacologist (ISSN 0031-7004) is published quarterly in March, June, ASPET Members Survey. page 67 September, and December by the American Society for Pharmacology and Experimental Therapeutics, 9650 Rockville Pike, Bethesda, MD 20814- Announcements 3995. Annual subscription rates: $20.00 for ASPET Members; $45.00 for Call for Award Nominations U.S. nonmembers and institutions; John J. Abel Award . page 68 $65.00 for nonmembers and institutions outside the U.S. Single copy: $20.00. Pharmacia-ASPET Award . page 69 Copyright © 2006 by the American Torald Sollmann Award . page 69 Society for Pharmacology and Experimental Therapeutics, Inc. All Epilepsy Research Award . page 70 rights reserved. Periodicals postage Julius Axelrod Award . page 71 paid at Bethesda, MD. GST number for Canadian subscribers: BN:13489 2330 Membership Information . page 72 RT. ASPET assumes no responsibility for Prices for the member subscriptions to the print version of the statements and opinions advanced by contributors to The Pharmacologist. The Pharmacologist went up in 2006 to $20 per year. Deadlines for submission of material for publication: Issue 1, March 1; Issue 2, This price increase is based on the actual cost to print and June 1; Issue 3, September 1; and Issue mail each edition of The Pharmacologist independent of any 4, December 1. of the costs involved in producing the content. Postmaster: Send address changes to: The Pharmacologist, ASPET, 9650 Rockville Pike, Bethesda, MD 20814- 3995. A Publication of the American Society for 46 Pharmacology and Experimental Therapeutics - ASPET Volume 48 Number 2, 2006 EXPERIMENTAL BIOLOGY 2006 – SAN FRANCISCO ASPET met as part of Experimental Biology 2006, April 1-5, 2006, in San Francisco, CA. Once again this year, both ASPET and Experimental Biology had record attendance. Here are some pictures from the meeting: Above: Attendees enjoy the opening reception and the student-mentor mixer Pictures from many of the division activities can be found on the following division websites: Behavioral Pharmacology: http://www.aspet.org/public/divisions/behavioral/news.htm Cardiovascular Pharmacology: http://www.aspet.org/public/divisions/cardiovascular/news.htm Drug Metabolism: http://www.aspet.org/public/divisions/drugmetab/divisionnews.htm Molecular Pharmacology: http://www.aspet.org/public/divisions/molpharm/news.htm Neuropharmacology: http://www.aspet.org/public/divisions/neuropharm/news.htm Systems and Integrative Pharmacology: http://www.aspet.org/public/divisions/sip/news.htm A Publication of the American Society for 47 Pharmacology and Experimental Therapeutics - ASPET Volume 48 Number 2, 2006 MESSAGE FROM THE PRESIDENT The end of one’s term of office for ASPET arrives all too quickly but provides an opportunity to reflect on the events that have transpired over the past year. It offers, as well, an occasion to comment on my perspectives of the status of the Society and its directions for the future. Although potentially dangerous, I revisited my “Candidate’s Statement” for the 2004 election to see how closely aligned those objectives and statements were with the course of activities that have occurred over the past year. They provide a suitable context for us to review the past year’s activities and provide a commentary, as well, on the current status and future directions of the Society. The first area of stated focus was that “ASPET must continue to serve and adapt to the needs of its existing members, while ensuring that it is able to attract and retain new members.” The very unfortunate occurrence and widespread devastation of Katrina in the Fall of 2005 prompted several initiatives by ASPET to assist members and students that were affected by the hurricane. In response to the impact of Katrina on ASPET members and students, ASPET Council established a Hurricane Katrina Relief Fund that provided grants to ASPET Student members and relief from expenses for the EB ’06 meeting for member scientists affected by the hurricane. Dues for members affected by Katrina were also waived for the current year. The funds were provided in part from the Society’s operating budget but also from the generous donations from ASPET members and GlaxoSmithKline (GSK). There were also responses from ASPET Journals and offers by members to host displaced scientists both in the home and in the laboratory. The response was significant and reassuring in attempting to help both students and members manage through a very difficult time. Although only a small segment of the Society’s members were affected, the larger base of support was indicative of the collegiality we have across our organization and certainly reflects ASPET’s ability to serve and adapt to the needs of its members, even under unforeseen and catastrophic circumstances. This adaptation by the Society to members whose areas are evolving in new directions has also been seen in our response to changes reflective of the normal and beneficial progression of science. Council has approved the change in name of the Division of Clinical Pharmacology to that of the Division of Clinical Pharmacology, Pharmacogenomics and Translational Medicine to embrace the emergence of these important scientific developments. One area of focus for the Society, led primarily by Jim Bernstein, ASPET Director of Government and Public Affairs, is that of “Integrative Pharmacology.” Despite the widespread recognition that this is an area where training has diminished considerably, but where the need for individuals trained in this area continues to accelerate, substantive responses to address this challenge have languished in the U.S. Jim organized a meeting in March of this year that brought several individuals from pharmaceutical companies together to hear Michael Collis, the founder of the Integrative Pharmacology Fund that has generated millions of dollars from both industry and government to support the training of in vivo, integrative pharmacologists in the U.K. This is an area of opportunity for ASPET to address critical training and resource needs. The ASPET-Merck Postdoctoral Fellowships in Integrative Pharmacology and the Short Courses in Integrative Organ Systems Science are very worthy initiatives in this endeavor, but more aggressive efforts are needed to bolster these initiatives. With regard to attracting new members, ASPET enrolled 471 new members over the past year. As part of our commitment to not only attract new members but to make sure we provide the services that our current members want, Council approved the creation of a new position, Member Services Marketing Manager. That position was filled in April by Suzie Thompson, also the Editor of this newsletter. Additionally, ASPET awarded 79 graduate student travel awards, 28 Young Scientist Travel Awards and 5 SURF Travel Awards to EB’06; 18 additional Institutional SURF awards were funded for 2006. ASPET is making 20 Graduate Student Awards and 7 James A. Bain Young Scientist Travel Awards to the upcoming IUPHAR Congress in Beijing. These are tremendous initiatives that foster early commitment to students in pharmacology, but further efforts must be made to ensure the continued growth and enhancement of the Society. A second area of emphasis was that “ASPET must continue to be diligent as well as proactive in its fiscal responsibility, implementing financial and revenue planning, while not compromising its member services, educational initiatives, or its preparation for the future.” As presented at the EB ’06 meeting by Pat Sonsalla, Secretary/Treasurer of ASPET, this is the first time in many years that the budget projected for the year will be ‘in the black.’ This is a reflection of some draconian changes that were implemented by Council in years past, by some A Publication of the American